CytoTherapeutics Inc, StemCells Inc deal

CTII completed its acquisition of StemCells for $7.9

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE